Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Jan 21, 2009

Premium

Scott Gottlieb, former FDA deputy commissioner, has joined the board of directors of CombiMatrix. Gottlieb is currently a resident fellow at the American Enterprise Institute and also serves as an attending physician at Stamford Hospital.


Qiagen has hired Tom Clement as vice president of regulatory and clinical affairs. He joins the firm from Roche Molecular Systems, where he was vice president of quality and regulatory. He has also held positions at Organon Teknika, Amersham, Biotech Research Laboratories, and elsewhere.

Filed under

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.